FDA panel says Merck's sleep drug safe, effective at lower dose

FDA panel says Merck's sleep drug safe, effective at lower dose

On Monday, the FDA's internal reviewers published a report expressing concern about the drug's potential to cause next-day sleepiness and impaired driving. They asked the committee to consider whether patients should be started at a lower dose than

3
Like
Save

Comments

Write a comment

*